Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Look at the Developments Behind the Big Moves of Five Stocks

Page 1 of 2

With the earnings season in progress, a number of stocks are registering significant moves on the back of earnings releases and other news. One of them, Ambarella Inc (NASDAQ:AMBA), opened 7% lower on Thursday, while Lifelock Inc (NYSE:LOCK)Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)InvenSense Inc (NYSE:INVN), and Hanesbrands Inc. (NYSE:HBI) are gaining ground in the first hours of trading. Let’s take a closer look at the developments that have set these stocks into motion today.

stocks, analysis, market, numbers, business, ticket, trade, money, price


We will also look at what the investors from our database think about some of these companies. By looking at the hedge fund sentiment we have determined that a retail investor can beat the market over the long-term. However, the key is not to look at the stocks that hedge funds are collectively the most bullish on, since these stocks are mainly represented by large- and mega-cap companies, which are more efficiently priced and are more widely covered. The key is to focus on the top small-cap ideas of hedge funds. Our strategy involves imitating the 15 most popular small-cap stocks among over 700 hedge funds and it has returned 102% since August 2012, beating the market by some 53 percentage points (see more details here).

Let’s start with Ambarella Inc (NASDAQ:AMBA), the only loser of the five-stock lot covered in this article, whose shares have declined by over 7%, not on the back of its earnings, but after GoPro Inc (NASDAQ:GPRO) released its financial results for the third quarter. Ambarella Inc (NASDAQ:AMBA) is one of the key chip suppliers for GoPro, therefore both stocks are very correlated. After GoPro missed estimates for the third quarter (see the details here) and its stock tanked by over 16%, Ambarella’s shares were also expected to take a hit as the demand for GoPro’s action cameras is falling. The sentiment among hedge funds towards Ambarella is also weak, with only 26 investors from our database reporting stakes equal to 13% of the company as of the end of June. Meanwhile, Louis Navellier‘s Navellier & Associates added 159,613 shares to its stake in Ambarella Inc (NASDAQ:AMBA) during the third quarter, as it reported holding 182,070 shares in its latest 13F.

Follow Ambarella Inc (NASDAQ:AMBA)
Trade (NASDAQ:AMBA) Now!

On the other hand, Lifelock Inc (NYSE:LOCK)‘s stock has soared by over 46% on the back of its most recent financial results as well as a settlement with the Federal Trade Commission. The provider of theft protection posted revenue of $151.95 million and adjusted net income of $0.28 per share, which were above the $123.03 million and $0.16 per share respectively that it delivered a year earlier. Moreover, the results were better than the EPS of $0.25 and revenue of $147.36 million expected by the Street. The settlement with the FTC is related to Lifelock Inc (NYSE:LOCK)’s past marketing representations and information security programs. At the end of June, 23 funds from our database held around 7.90% of Lifelock Inc (NYSE:LOCK)’s outstanding stock. In addition, Billionaire Ken Fisher‘s Fisher Asset Management reported holding 335,998 shares of Lifelock as of the end of September.

Follow Lifelock Inc. (NYSE:LOCK)
Trade (NYSE:LOCK) Now!

On the following page we will discuss the three other stocks that surged on the back of solid quarterly results.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!